Article Text

Download PDFPDF

Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes
  1. Maria J Redondo1,
  2. Jesse Muniz2,
  3. Luisa M Rodriguez1,
  4. Dinakar Iyer3,
  5. Fariba Vaziri-Sani4,
  6. Morey W Haymond5,
  7. Christiane S Hampe6,
  8. Michael L Metzker2,
  9. Struan F A Grant7,
  10. Ashok Balasubramanyam3
  1. 1Department of Pediatrics, Section of Diabetes and Endocrinology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA
  2. 2Department of Genetics, Human Genome Center, Baylor College of Medicine, Houston, Texas, USA
  3. 3Division of Diabetes, Translational Metabolism Unit, Diabetes Research Center, Endocrinology and Metabolism, Baylor College of Medicine, Houston, Texas, USA
  4. 4Department of Clinical Sciences, Diabetes and Celiac Disease, Lund University/CRC, Malmö, Sweden
  5. 5Childrens's Nutrition Research Center, Baylor College of Medicine, Houston, Texas, USA
  6. 6Department of Medicine, University of Washington, Seattle, Washington, USA
  7. 7Division of Human Genetics and Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Maria J Redondo; redondo{at}bcm.edu

Abstract

Background The transcription factor 7-like 2 (TCF7L2) gene has the strongest genetic association with type 2 diabetes. TCF7L2 also associates with latent autoimmune diabetes in adults, which often presents with a single islet autoantibody, but not with classical type 1 diabetes.

Methods We aimed to test if TCF7L2 is associated with single islet autoantibody expression in pediatric type 1 diabetes. We studied 71 prospectively recruited children who had newly diagnosed type 1 diabetes and evidence of islet autoimmunity, that is, expressed ≥1 islet autoantibody to insulin, glutamic acid decarboxylase 65, islet cell autoantigen 512, or zinc transporter 8. TCF7L2 rs7903146 alleles were identified. Data at diagnosis were cross-sectionally analyzed.

Results We found that 21.1% of the children with autoimmune type 1 diabetes expressed a single islet autoantibody. The distribution of TCF7L2 rs7903146 genotypes in children with a single autoantibody (n=15) was 40% CC, 26.7% CT and 33.3% TT, compared with children with ≥2 islet autoantibodies (50% CC, 42.9% CT and 7.1% TT, p=0.024). Furthermore, compared with children with ≥2 autoantibodies, single-autoantibody children had characteristics reflecting milder autoimmune destruction of β-cells. Restricting to lean children (body mass index<85th centile; n=36), 45.5% of those expressing a single autoantibody were rs7903146 TT homozygotes, compared with 0% of those with ≥2 autoantibodies (p<0.0001).

Conclusion These results suggest that, in children with only mild islet autoimmunity, mechanisms associated with TCF7L2 genetic variation contribute to diabetogenesis, and this contribution is larger in the absence of obesity.

  • Pediatric Type 1 Diabetes
  • Transcription Factor
  • LADA (Latent Autoimmune Diabetes in Adults)
  • Autoantibodies

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.